celecoxib and Bright Disease studies

celecoxib and Bright Disease

celecoxib has been researched along with Bright Disease in 3 studies

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research Excerpts

Excerpt	Relevance	Reference
"Treatment with celecoxib increased cortical alpha(v) integrin mRNA expression 2."	1.32	Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression. ( Grabensee, B; Heering, P; Heise, G; Meyer-Kirchrath, J; Schrör, K; Waldner, C, 2003)
"In celecoxib-treated PHN rats (group D) the mRNA expression of the EP3 and EP4 receptors was significantly reduced to 1."	1.32	COX-2 inhibition and prostaglandin receptors in experimental nephritis. ( Heering, P; Heise, G; Schrör, K; Waldner, C, 2003)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

3 (100.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Waldner, C	2
Heise, G	2
Meyer-Kirchrath, J	1
Schrör, K	2
Grabensee, B	1
Heering, P	2
Zhang, L	1
Bertucci, AM	1
Smith, KA	1
Xu, L	1
Datta, SK	1

Studies

Waldner, C

Heise, G

Meyer-Kirchrath, J

Schrör, K

Grabensee, B

Heering, P

Zhang, L

Bertucci, AM

Smith, KA

Xu, L

Datta, SK

Other Studies

3 other studies available for celecoxib and Bright Disease

Article	Year
Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression. Nephron. Experimental nephrology, 2003, Volume: 93, Issue:2 Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female	2003
COX-2 inhibition and prostaglandin receptors in experimental nephritis. European journal of clinical investigation, 2003, Volume: 33, Issue:11 Topics: Animals; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase I	2003
Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus. Arthritis and rheumatism, 2007, Volume: 56, Issue:12 Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Apoptosis; B-Lymphocytes; Celecoxib; Cycloox	2007

Article

Year

Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression.

Nephron. Experimental nephrology, 2003, Volume: 93, Issue:2

Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female

2003

COX-2 inhibition and prostaglandin receptors in experimental nephritis.

European journal of clinical investigation, 2003, Volume: 33, Issue:11

Topics: Animals; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase I

2003

Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.

Arthritis and rheumatism, 2007, Volume: 56, Issue:12

Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Apoptosis; B-Lymphocytes; Celecoxib; Cycloox

2007